← FDA Drug Approvals (Drugs@FDA)

PITAVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2019-04-04

Drug application

FDA Application #

ANDA206070

Application type

Abbreviated New Drug Application (Generic)

Brand name

PITAVASTATIN CALCIUM

Generic name

PITAVASTATIN

Active ingredients

PITAVASTATIN CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2019-04-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown